This collection contains detailed discussion of potentially difficult aspects of recent recommendations for the classification of chronic interstitial pneumonias, challenging areas of the upcoming WHO ...
SAN ANTONIO, January 07, 2026--bioAffinity's laboratory, Precision Pathology Laboratory Services, maintains accreditation from the College of American Pathologists ...
Philadelphia, April 30, 2025 – Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive ...
In conclusion, COPD is a global disease, with increasing prevalence and health-related impact. The loss of FEV 1 may be slowing down, but what is really needed is an intervention that improves it in ...
(Boston)—Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs ...
Type 2 diabetes and prediabetes can both significantly impact pulmonary health, highlighting the need for early detection and intervention. A new paper has highlighted the significant impact of type 2 ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback